Loading...

TECX TECTONIC THERAPEUTIC INC Expansion Plans 8-K Filing

TCTN

TCX

TECTONIC THERAPEUTIC INC

(TECX)

2025 8-K

Financial Results Update

Financial Results Update

Positive Data Release

Financial Statements

Product Expansion

Financial Statements

Financial Results

Securities Agreement

Positive Trial Data

Corporate Update

Financial Results

Positive Trial Results

Financial Results

FDA Clearance of IND Applic...

Departure of Officer

Corporate Presentation Upda...

Management Changes

Merger Closing Delayed and ...

Merger Agreement and Revers...

Merger Approval

Merger and Litigation

Merger Presentation

Merger Agreement

Compliance with Minimum Bid...

Termination, Asset Sale, Co...

Departure of Directors or C...

Sale of Cystinosis Program

Clinical Trial Results

Financial Results

Resignation and Appointment

Earnings Reports

Compliance with Minimum Bid...

External Links:

On October 29, 2025, Tectonic Therapeutic, Inc. announced positive topline data from its Phase 1b clinical trial for TX45 in patients with pulmonary hypertension associated with heart failure. This is a significant event for the company, reflecting potential progress in their research.

AI Assistant

TECTONIC THERAPEUTIC INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.